117 related articles for article (PubMed ID: 36050250)
1. Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].
Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
Cancer Lett; 2022 Nov; 548():215897. PubMed ID: 36050250
[No Abstract] [Full Text] [Related]
2. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer.
Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
Cancer Lett; 2019 Sep; 459():204-215. PubMed ID: 31199988
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65-74].
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2022 Aug; 540():215739. PubMed ID: 35599097
[No Abstract] [Full Text] [Related]
4. Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].
Bogusławska J; Rodzik K; Popławski P; Kędzierska H; Rybicka B; Sokół E; Tański Z; Piekiełko-Witkowska A
Cancer Lett; 2020 Jun; 480():52-55. PubMed ID: 32005526
[No Abstract] [Full Text] [Related]
5. Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81].
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2022 Oct; 545():215836. PubMed ID: 35934602
[No Abstract] [Full Text] [Related]
6. KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression.
Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft' [Canc. Lett. 330 (2013) 22-32].
Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
Cancer Lett; 2021 Dec; 522():282. PubMed ID: 34565620
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer" [Canc. Lett. 374 (2016) 292-303].
Yong X; Tang B; Xiao YF; Xie R; Qin Y; Luo G; Hu CJ; Dong H; Yang SM
Cancer Lett; 2022 Dec; 551():215961. PubMed ID: 36280526
[No Abstract] [Full Text] [Related]
9. Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].
Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
Cancer Lett; 2021 Feb; 498():240-241. PubMed ID: 33221059
[No Abstract] [Full Text] [Related]
10. Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer.
Kleeff J; Friess H; Simon P; Susmallian S; Büchler P; Zimmermann A; Büchler MW; Korc M
Dig Dis Sci; 1999 Sep; 44(9):1793-802. PubMed ID: 10505717
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner" [Canc. Lett. 371 (2016) 354-365].
Zheng S; Chen H; Wang Y; Gao W; Fu Z; Zhou Q; Jiang Y; Lin Q; Tan L; Ye H; Zhao X; Luo Y; Li G; Ye L; Liu Y; Li W; Li Z; Chen R
Cancer Lett; 2022 Oct; 545():215859. PubMed ID: 35940956
[No Abstract] [Full Text] [Related]
12. Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling" [Canc. Lett. 471 (2020) 135-146].
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2022 Nov; 549():215913. PubMed ID: 36152564
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2021 Mar; 500():292-293. PubMed ID: 33390287
[No Abstract] [Full Text] [Related]
14. Corrigendum to "UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation" [Canc. Lett. 494 (2020) 121-131].
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2022 Sep; 543():215792. PubMed ID: 35718664
[No Abstract] [Full Text] [Related]
15. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
16. USP4 promotes invasion of breast cancer cells via Relaxin/TGF-β1/Smad2/MMP-9 signal.
Cao WH; Liu XP; Meng SL; Gao YW; Wang Y; Ma ZL; Wang XG; Wang HB
Eur Rev Med Pharmacol Sci; 2016; 20(6):1115-22. PubMed ID: 27049265
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway.
Hu J; Chen Y; Huang Y; Su Y
Exp Mol Pathol; 2020 Aug; 115():104468. PubMed ID: 32445750
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation.
Cave DD; Di Guida M; Costa V; Sevillano M; Ferrante L; Heeschen C; Corona M; Cucciardi A; Lonardo E
Oncogene; 2020 May; 39(21):4271-4285. PubMed ID: 32291413
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
[No Abstract] [Full Text] [Related]
20. Corrigendum to "SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission" [Canc. Lett. 547 (2022) 215871].
Wang M; Wei R; Li G; Bi HL; Jia Z; Zhang M; Pang M; Li X; Ma L; Tang Y
Cancer Lett; 2022 Nov; 549():215923. PubMed ID: 36166936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
